News

Tricked-Out Immune Cells Could Attack Cancer, Spare Healthy Cells

UC San Francisco scientists have created a new class of highly customizable biological sensors that can be used to form “logic gates” inside cells of the immune system, giving these cells the capability to home in on and kill a wide range of cancer cells while preventing them from attacking normal

For Breast Cancer Patients, Never Too Late To Quit Smoking

Documenting that it’s never too late to quit smoking, a large study of breast cancer survivors has found that those who quit smoking after their diagnosis had a 33 percent lower risk of death as a result of breast cancer than those who continued to smoke. The study involved more than 20,600 women

HDFCCC Joins Nation's Cancer Centers in Endorsement of HPV Vaccination for Cancer Prevention

In response to low national vaccination rates for the human papillomavirus (HPV), the UCSF Helen Diller Family Comprehensive Cancer Center has joined the other 68 NCI-designated cancer centers in issuing a statement urging for increased HPV vaccination for the prevention of cancer. These

Are We Ready for a Blood Test for Cancer?

What if screening for cancer was as easy as checking your cholesterol? That’s the promise of techniques currently in development that may one day make it possible to detect the earliest stages of cancer with an annual blood draw. So-called "liquid biopsies" involve extracting free-floating cancer

E-cigarettes, as Used, Aren't Helping Smokers Quit, Study Shows

Electronic cigarettes are widely promoted and used to help smokers quit traditional cigarettes, but a new analysis from UC San Francisco found that adult smokers who use e-cigarettes are actually 28 percent less likely to stop smoking cigarettes. The study — a systematic review and meta-analysis of

NCCN Awards Research Grants to Five Investigators to Study Effectiveness of Enzalutamide in Various Cancers

FORT WASHINGTON, PA — The National Comprehensive Cancer Network ® ( NCCN ® ) Oncology Research Program ( ORP ) has awarded five grants to investigators to evaluate and define the pre-clinical and clinical effectiveness of enzalutamide in mantle cell lymphoma and endometrial, hepatocellular, and

Biochemist James Wells Among 12 UC Innovators Elected to National Academy of Inventors

Thirteen University of California innovators have been elected as fellows to the prestigious National Academy of Inventors for work that is transforming semiconductor manufacturing, boosting the efficiency of biofuels and saving lives through the creation of new biomedical technologies. The newest